http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62261962-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09ca043d7e596facff1f44b746e2f4d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
filingDate 1986-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b48b5ad87f13f546e152638a077bd1a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31c0cfdded0370b3721445de456dbebb
publicationDate 1987-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S62261962-A
titleOfInvention Liquid control serum for lipid component
abstract PURPOSE: To obtain a liquid control serum which has an excellent shelf life and does not hinder measurement by adding a prescribed of an alanine, ethylenediaminetetraacetic acid and prescribed surface active agent to a serum. n CONSTITUTION: The alanine, ethylenediaminetetraacetic acid and polyoxyethylene ether type nonionic surface active agent are added to the serum. The amt. of the alanine to be added to the serum is 2.0W4.0wt%, more preferably about 3.0wt%. The amt. of the ethylenediaminetetraacetic acid to be added is 1.0W3.0wt%, more preferably about 1.5wt%. The amt. of the surface active agent to be added is 0.10W0.30wt%. The serum may be derived from human or animal. The control serum having a high effect of stabilizing lipid is obtd. by adding the alanine thereto. The preservation for a long period of time is permitted by the addition of the above-mentioned surface active agent. n COPYRIGHT: (C)1987,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011105257-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-400199-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5770451-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889237-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101995476-A
priorityDate 1986-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S58141797-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57163500-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5784356-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59122952-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049

Total number of triples: 28.